Graham Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,859
Closed -$285K – 1424
2026
Q2
$285K Sell
2,859
-470
-14% -$47.3K 0.01% 915
2026
Q1
$294K Sell
3,329
-394
-11% -$33.9K 0.01% 819
2025
Q4
$292K Buy
+3,723
New +$283K 0.01% 869
2022
Q4
– Sell
-6,796
Closed -$957K – 1212
2022
Q3
$957K Buy
6,796
+3,062
+82% +$559K 0.04% 507
2022
Q2
$761K Buy
3,734
+2,728
+271% +$597K 0.03% 524
2022
Q1
$256K Buy
+1,006
New +$273K 0.01% 775

Other funds holding MLAB

Graham Capital Management's MLAB Position: Q3 2026 in Review

Graham Capital Management sold out of Mesa Laboratories (MLAB) in Q3 2026, closing a stake of 2,859 shares — an estimated $285K sold.

Graham Capital Management first reported a position in MLAB in Q1 2022 and held it in 6 quarters. The position peaked at $957K in Q3 2022. 184 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Graham Capital Management reported no remaining Mesa Laboratories position as of Q3 2026 after selling out during the quarter.
  • Graham Capital Management sold 2,859 Mesa Laboratories shares in Q3 2026, an estimated $285K.
  • Graham Capital Management first reported a position in Mesa Laboratories in Q1 2022 and held it in 6 quarters.
  • Graham Capital Management's Mesa Laboratories position peaked at $957K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Graham Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.